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Maria N. Manaca2, Diana Barrios1, Pau Cisteró1, Caterina Guinovart1,2, Ruth Aguilar1,2, Azucena Bardajı́1,
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Abstract
Age- and exposure-dependent immune responses during a malaria episode may be key to understanding the role of these
factors in the acquisition of immunity to malaria. Plasma/serum samples collected from naı̈ve Mozambican children (n = 48),
European adults (naı̈ve travelers, n = 22; expatriates with few prior malaria exposures, n = 15) and Mozambican adults with
long-life malaria exposure (n = 99) during and after a malaria episode were analyzed for IgG against merozoite proteins by
Luminex and against infected erythrocytes by flow cytometry. Cytokines and chemokines were analyzed in plasmas/sera by
suspension array technology. No differences were detected between children and adults with a primary infection, with the
exception of higher IgG levels against 3D7 MSP-142 (P = 0.030) and a P. falciparum isolate (P = 0.002), as well as higher IL-12
(P = 0.020) in children compared to other groups. Compared to malaria-exposed adults, children, travelers and expatriates
had higher concentrations of IFN-c (P#0.0090), IL-2 (P#0.0379) and IL-8 (P#0.0233). Children also had higher IL-12
(P = 0.0001), IL-4 (P = 0.003), IL-1b (P = 0.024) and TNF (P = 0.006) levels compared to malaria-exposed adults. Although IL-12
was elevated in children, overall the data do not support a role of age in immune responses to a first malaria episode. A TH1/
pro-inflammatory response was the hallmark of non-immune subjects.
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for International Cooperation and Development (AECID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation
of the manuscript.
Competing Interests: The co-author AM is a PLOS ONE Editorial Board member. This does not alter the authors’ adherence to all the PLOS ONE policies on
sharing data and materials.
* E-mail: gemma.moncunil@cresib.cat
. These authors contributed equally to this work.
Introduction
The worldwide burden of disease from malaria remains a major
public health problem, with approximately 216 million cases and
655,000 deaths in 2010, with the majority of deaths occurring in
sub-Saharan Africa [1]. In areas where malaria is endemic,
children together with pregnant women are the most susceptible
populations. Children suffer more malaria episodes and are more
prone to severe malaria compared to adults [2]. With increasing
age, there is a shift from severe malaria to clinical malaria and
eventually to asymptomatic parasitemia, but immunity is never
sterilizing. Malaria exposure but also age may have an effect on
the natural acquisition of immunity as the immune system of
children is not totally mature [3,4]. After several decades of
investigation in animal models and humans, the mechanisms
involved in naturally acquired immunity and immunopathology
are still poorly defined, partly because it is difficult to separate the
effects of age from those of repetitive exposure. There is no clear
evidence for an effect of age at first exposure to Plasmodium
falciparum in the development of immunity in African children
[5,6], although previous studies in malaria – naı̈ve migrants in
Indonesia suggested that the more mature immune system from an
adult may allow acquisition of immunity more rapidly than the less
mature immune system from a child under the same conditions of
exposure [7,8]. Totally naı̈ve adults such as travelers or migrants
never exposed to P. falciparum going to malaria-endemic areas are
also more susceptible to clinical and severe malaria than adults
from endemic areas [2,9,10]. Furthermore, it has been suggested
that naı̈ve adults are initially more susceptible to severe disease
than children [2,11] and show different clinical presentations [12].
In this study, we aimed to determine (i) the effect of age on
cytokine, chemokine and Immunoglobulin G (IgG) responses in
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children and adults during the acute and convalescent phases of a
first P. falciparum malaria episode and (ii) the effect of exposure on
immune responses in adults during the acute and convalescent
phases of a malaria episode. We hypothesized that the immune
response of children during a first malaria episode would be
quantitatively and qualitatively different from the immune response
of naı̈ve adults. Further, we hypothesized that during a malaria
episode the immune response in naı̈ve adults would be quantitatively
and qualitatively different from immune responses in adults with
different levels of prior exposure to P. falciparum infection.
Materials and Methods
Ethics Statement
Written informed consent was obtained from participants or
their respective parents or guardians before sample collection.
Parasitemic individuals were treated according to standard
national guidelines at the time of the studies. Approval for the
protocols was obtained from the National Mozambican Ethics
Review Committee and the Hospital Clı́nic of Barcelona Ethics
Review Committee.
Study design, patients and sample collection
All volunteers included in this study had an acute clinical malaria
episode at the moment of recruitment and/or sample collection.
There were four groups of patients: (i) naı̈ve children from a malaria
endemic area with a first episode (ii) naı̈ve adults from a non-
endemic area with a first episode (travelers) (iii) other non-immune
adults temporarily resident in an endemic area (expatriates) and (iv)
adults from an endemic area (malaria-exposed).
Children were recruited in the context of a study conducted at
the Centro de Investigação em Saúde de Manhiça, Manhiça
District, southern Mozambique, where transmission of P. falciparum
is perennial, with some seasonality of moderate intensity. Forty
eight children presenting a first malaria episode were chosen from
a total of 287 followed up from birth to age 24 months in a three-
arm randomized, double-blind, placebo-controlled trial with
monthly chemoprophylaxis with sulfadoxine-pyrimethamine and
artesunate between 2005 and 2009 [5]. Children had been
followed up by a combination of active and passive case detection.
Blood samples were collected into EDTA microtainers by finger-
prick at acute episode (day 0) and at convalescence after treatment
(day 28). Two blood smears and blood spots onto filter paper
(Schleicher and Schuell; no. 903TM) were used to determine
parasitemia by microscopy [5] and PCR, respectively.
Travelers and expatriates were European adults without
previous malaria exposure (22 travelers) or who have lived in a
malaria endemic area for a minimum of one year (15 expatriates).
They were recruited at the Tropical Medicine Unit in the Hospital
Clı́nic de Barcelona, Spain, between 2005 and 2009, and
diagnosed with P. falciparum malaria by microscopy after traveling
to an African country. Blood samples from acute episodes (day 0)
and convalescence after malaria treatment (days 7 and 28) were
collected by venipuncture into one heparin vacutainer for infected
erythrocyte (IE) pellet cryopreservation in glycerolyte solution, and
one vacutainer without anticoagulant for serum cryopreservation
at 280uC. Two blood drops from each sample were spotted onto
filter paper for parasite PCR analysis.
Malaria-exposed adults with life-long exposure to P. falciparum
were non-pregnant women and men recruited from patients
attending the Manhiça District Hospital, Mozambique, with
clinical malaria between 2004 and 2005 [13]. Blood samples were
collected by venipuncture into heparin tubes and plasma samples
were cryopreserved at 280uC. Two blood drops from each sample
were spotted onto filter paper for parasite PCR detection.
Recombinant proteins
Apical membrane antigen 1 (AMA-1) from the 3D7 strain [14],
the receptor-binding region F2 of the 175 kDa erythrocyte binding
antigen from the CAMP strain (EBA-175; F2 region) [15], the
Duffy binding-like alpha (DBL-a) domain of PfEMP-1 [16] and
the DBL3X domain of VAR2CSA PfEMP-1 [17] were produced
as recombinant proteins at ICGEB. AMA-1 from FVO strain and
MSP-142 from 3D7 and FVO strains [18,19] were produced as
recombinant proteins at WRAIR.
Antibody levels to recombinant proteins
A multiplex suspension array technology panel was established
to quantify IgG responses to P. falciparum antigens using Luminex
xMAPTM (Luminex Corp., Austin, Texas) and the Bio-Plex 100
platform (Bio-Rad, Hercules, California) [20]. Briefly, 3,000
microspheres per analyte were used per sample test. A pool from
hyper-immune Mozambican adult volunteers at dilution 1/30,000
and samples from non-exposed European adults at dilution 1/
1,000 were added in duplicates to each plate as positive and
negative controls, respectively. Study samples were tested in
duplicates at dilutions 1/1,000 and 1/30,000, but only 1/1,000
was chosen for the statistical analysis because of a wider
quantitative dynamic range. In some wells no serum/plasma was
added as a control of background. Beads were incubated with
serum/plasma samples for 1 h. The plate was washed by pelleting
microspheres (centrifuge at 800 g for 5 min) and resuspended with
0.05% Tween 20-PBS. One hundred mL of biotinylated anti-
human IgG (Sigma, Tres Cantos, Spain) diluted 1/2,500 in assay
buffer were applied and incubated for 45 min. The plate was
washed as before, and 100 mL of streptavidin-conjugated R-
phycoerythrin (Invitrogen, Carlsbad, California) diluted 1/1,000
in assay buffer were added and incubated for 25 min. All
incubations were done at room temperature (RT) with plate
agitation and protection from light. The plate was read using Bio-
Plex Manager version 4.0, and at least 100 microspheres per
analyte were acquired per sample. Mean fluorescent intensity
(MFI) with background fluorescence subtracted was exported and
arbitrary units (AU) concentration for each antigen was calculated
by dividing MFI of each sample by the MFI of the positive control
run in each plate.
Antibodies to IEs surface antigens
Two laboratory clones (CS2, R29), 3 isolates collected from
travelers to endemic regions (IETrav1, IETrav2, IETrav3), 2 pediatric
isolates from Mozambican children, one with uncomplicated
malaria (IECh1) and another with severe malaria (IECh2) and 1
isolate from a pregnant Mozambican woman (IEWoman), each of
whom had the O blood group, were tested for recognition by IgG
using flow cytometry. Study samples were tested blindly in a single
assay against each parasite. A pool of plasma samples from
immune Mozambican adults and a pool of plasma samples from
non-exposed European adults were included as positive and
negative controls, respectively. Cryopreserved ring-stage parasites
were thawed in a sorbitol gradient and grown to late trophozoites.
Cells were washed 3 times in PBS and resuspended at 1%
hematocrit and 1–5% parasitemia in 1% BSA-PBS solution. Five
mL of plasma were added to 95 mL/well of erythrocyte suspension,
incubated for 30 min at RT and stained for 30 min with 100 mL
of polyclonal rabbit anti-human IgG (DakoCytomation) at 1/200.
Subsequently, cells were incubated with 100 mL of AlexaFluorH-
conjugated donkey anti-rabbit IgG (Invitrogen) diluted at 1/1,000
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and 10 mg/mL of ethidium bromide (Ecogen) for 30 min in
darkness at RT. Samples were washed 3 times with PBS-BSA
between incubations. Data from 1,000 positive events was
acquired with a Becton-Dickinson (BD) FACSCalibur flow
cytometer. Reactivity against IE surface antigens was expressed
as the difference between the MFI of IEs and the MFI of
uninfected erythrocytes.
Cytokine/chemokine concentrations in plasma/serum
Concentrations (pg/mL) of interleukin (IL)-12p70, IL-2, IFN-c,
IL-4, IL-5, IL-10, IL-8, IL-6, IL-1b, TNF and TNF-b in plasma
and serum were measured using a commercial multiplex
suspension array technology kit (Human Th1/Th2 11plex
FlowCytomix kit, Bender MedSystems) and flow cytometry.
Twenty-five mL of plasma or serum were tested following
manufacturer’s instructions. MFI from microspheres was acquired
with a BD FACSCanto II and analyzed in FlowCytomix Pro2.2.1
software (Bender MedSystems). Concentration of each analyte was
obtained by interpolating fluorescence intensity to a 7-point
dilution standard curve supplied by the manufacturer. Any value
below the limits of detection was given a value of half the detection
limit for that cytokine. TNF-b was excluded from the statistical
analysis since levels in most samples (226/233, 97%) were below
the limit of detection.
Statistical methods
Recognition of recombinant proteins and parasites by antibod-
ies was considered positive if AU or MFI values were above the
mean of the negative controls plus 2 standard deviations for each
antigen. Threshold values for seroprevalence were: 238.02 AU for
AMA-1 3D7; 1134.73 AU for AMA-1 FVO; 921.18 AU for MSP-
142 3D7; 638.33 AU for MSP-142 FVO; 3110.36 AU for EBA-
175; 1572.55 AU for DBL-a; and 217.44 AU for DBL3X.
Comparisons between groups for categorical variables were done
using x2test or Fisher’s exact test. Continuous variables were
analyzed using the non-parametric Kruskal Wallis test or the
Mann-Whitney U test. Correlations within groups were assessed
by Spearman’s rank coefficient. All p-values were two-sided and
considered statistically significant when ,0.05. All data collected
were analyzed using Stata version 11.0 (Stata Corporation,
College Station, Texas, USA).
Results
Description of participants
Table 1 details the characteristics of the study subjects. There
were significant differences in the median age between children,
travelers, expatriates and malaria-exposed individuals and no
significant differences in the gender distribution. Children with no
documented prior malaria episodes and malaria-exposed adults
were from malaria endemic areas of Mozambique, whereas
travelers and expatriates were from non-malaria endemic coun-
tries. Travelers had never experienced malaria before, whereas
expatriates had lived in malaria endemic areas and 12 out of 15
reported at least one previous malaria episode. Malaria-exposed
adults were individuals living in P. falciparum malaria endemic
regions presenting with an episode of clinical malaria. There were
no differences in parasite densities between travelers and
expatriates and between children and malaria-exposed adults.
Some children were born to mothers with placental malaria
infection defined as having malaria pigment or parasites in the
placenta (10 out of 38 mothers, 10 unknown) and 3 children had
cord blood that was PCR positive for P. falciparum.
IgG antibody responses during a first malaria episode
IgG antibody levels against recombinant proteins and P. falciparum
IEs were measured in children and travelers presenting with a first
malaria episode on the day of malaria diagnosis and at convales-
cence. Merozoite proteins AMA-1, MSP-142, EBA-175 were chosen
because they are involved in essential parasite functions (erythrocyte
invasion) and are targets of naturally acquired antibodies associated
with malaria immunity and thus are leading vaccine candidates [21–
25]. The R29 isolate was used because it forms rosettes, a
mechanism involved in severe malaria, and that predominantly
expresses a group A PfEMP-1 [13], to which antibodies are rapidly
acquired in children [26]. DBL-a is a PfEMP-1 domain cloned from
the R29 lab isolate that is involved in rosetting through adhesion to
complement receptor 1 (R29var1 [27]). In addition, prior pilot
studies with several laboratory parasite isolates in the Manhiça area
showed that R29 is the most immunogenic when measuring IgGs to
variant surface antigens (VSA) (data not shown). The CS2 strain was
included because it is a parasite isolate from pregnant women that
binds to CSA, and an extensive and persistent recognition of
VAR2CSA by plasma from children has been reported [28]. Finally,
DBL3X was included because it is a VAR2CSA domain involved in
CSA binding.
IgG antibody levels in plasma against recombinant proteins and
IEs were not significantly different in children and travelers during
a first malaria episode with the exception of MSP-142 3D7 and
IEWoman isolate (Table 2). Children had higher levels of IgG
against MSP-142 3D7 and IEWoman than travelers (P = 0.030 and
P = 0.002, respectively). Similarly, there were no differences in
antibody prevalences or in breadth of response (data not shown)
with the exception of IgG prevalence against MSP-142 3D7 that
was higher in children than travelers (P = 0.027) (Table 2).
At convalescence, there were no significant differences in IgG
levels or prevalences to recombinant proteins (Table 3). Children
born from mothers with placental malaria infection did not show
any significant differences in antibody responses compared to
those born from mothers without placental malaria infection (data
not shown).
Cytokine and chemokine responses during a first malaria
episode
Cytokine and chemokine concentrations in plasma or serum
were measured in children and travelers with a first malaria acute
episode and during convalescence. No differences were detected in
any of the cytokines/chemokines tested with the exception of IL-
12 (Figure 1A). In the acute phase, children had significantly
higher levels of IL-12 than travelers (median {IQR} of 13.33
{0.75; 191.81} pg/mL and 0.75 {0.75; 17.98} pg/mL, respec-
tively; P = 0.020). During convalescence children had significantly
higher levels of IL-10 (14.66 {6.09; 70.81} pg/mL) compared to
travelers (0.95 {0.95; 0.95} pg/mL, P = 0.003). The day 0/day 28
ratio was significantly higher for IL-12 in children compared to
travelers (2.66 {0.89; 72.89} and 0.52 {0.03; 1.00}, respectively;
P = 0.026) and significantly lower for IL-10 (16.41 {.46; 110.16}
and 277.33 {100.77; 1406.74}, respectively; P = 0.015) (Figure 1B).
IL-10 levels correlated moderately with parasite density in both
groups whereas IL-8, IL-6 and IL-1b concentrations correlated
only in travelers (Table S2). There were no correlations between
cytokine and antibody levels (data not shown). In children, no
association was found between cytokine levels and being born
from a mother with placental malaria (data not shown).
Immune Responses First Malaria Episode
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Table 1. Characteristics of the study participants.
Characteristics Children Travelers Expatriates Malaria-exposed P-value
Day 0, n 48 22 15 99
Day 7, n 0 12 10 0
Day 28, n 28 6 4 0
Age, median years (IQR) 1.1 (0.9; 1.4) 31 (28; 38) 53 (45; 60) 26 (19; 36) ,0.001 a
Male, n (%) 26 (54) 15 (75) 7 (58) 52 (53) 0.320 b
Origin, n (%)
African 48 (100) 0 (0) 0 (0) 99 (100)
European 0 (0) 17 (85) 15 (100) 0 (0)
Others 0 (0) 3 (15) 0 (0) 0 (0)
Previous malaria episodes, n (%) 0 (0) 0 (0) 12 (80) 99 (100) c ,0.001 b
Parasitemia by thin smear
microscopy, %
ND 0.08 (0.01; 0.80) 0.06 (0.01; 0.19) ND 0.888 d
Parasitemia by thick smear
microscopy, parasites/ml e
26032 (9608; 45926) ND ND 35379 (14338; 61176) 0.091 d
Abbreviations: IQR, interquartile range; ND, not determined.
aKruskal Wallis test.
bx2.
cData presumed due to the long-lived exposure to malaria of malaria-exposed adults in the living area.
dMann-Whitney test.
eParasitemia data was available in 45 children, 20 travelers, 14 expatriates, 90 malaria-exposed adults.
doi:10.1371/journal.pone.0055756.t001
Table 2. Plasma IgG antibody levels and seroprevalences (number and % of responders) against recombinant proteins and IEs
surface antigens in children and naı̈ve adults in the acute phase of a first P. falciparum malaria episode.
IgG levels (AU) Prevalences





Antigen Median (IQR) Median (IQR) P-value a n % n % P-value b
Proteins c
AMA-1 3D7 758.74 (202.22; 8402.47) 287.84 (77.22; 1471.94) 0.075 19 68 9 45 0.144
AMA-1 FVO 1036.82 (477.63; 7260.11) 823.74 (293.71; 4171.51) 0.403 11 39 6 30 0.555
MSP-1 3D7 3369.76 (1578.10; 14002.25) 1172.45 (389.85; 8370.79) 0.030 23 82 10 50 0.027
MSP-1 FVO 1094.26 (301.89; 13641.75) 745.68 (147.21; 6985.65) 0.380 15 54 8 40 0.394
EBA-175 358.73 (21.30; 802.77) 344.32 (8.54; 663.42) 0.900 0 0 0 0 ND
DBLa 493.55 (220.83; 901.79) 849.98 (220.35; 1091.30) 0.452 4 14 3 15 1.000
DBL3X 114.06 (76.11; 309.35) 133.02 (50.62; 329.63) 0.786 8 29 6 30 1.000
IEs
IETrav1 26.43 (22.87; 32.30) 25.3 (20.31; 33.22) 0.458 7 23 4 20 1.000
IETrav2 30.75 (26.69; 39.98) 32.56 (26.28; 43.48) 0.678 8 27 7 35 0.547
IETrav3 10.23 (8.00; 13.77) 9.23 (7.74; 11.70) 0.294 2 7 1 5 1.000
CS2 8.91 (8.09; 9.22) 9.62 (8.84; 10.46) 0.057 3 10 0 0 0.265
R29 13.65 (11.27; 15.93) 16.93 (12.81; 22.07) 0.083 6 20 7 35 0.327
IECh1 3.21 (2.06; 5.12) 2.7 (1.89; 3.13) 0.148 3 10 1 5 0.641
IEWoman 3.76 (3.32; 4.45) 3.16 (2.68; 3.44) 0.002 3 10 1 5 0.641
IECh2 0.73 (0.47; 1.83) 0.62 (0.13; 1.18) 0.201 6 20 2 10 0.450
Abbreviations: AU, Arbitrary units; IQR, interquartile range; ND, not determined; IEs, infected erythrocytes.
aMann-Whitney test.
bFisher’s exact test.
cDeterminations were done in children n = 29.
doi:10.1371/journal.pone.0055756.t002
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IgG antibody responses in differently malaria-exposed
individuals
To study how exposure to malaria is affecting the IgG antibody
responses to different antigens, we compared IgG levels (Table 4)
and prevalences (Table S1) in children, travelers and expatriates
versus life-long malaria-exposed adults. Individuals with a primo-
infection (children and travelers) had significantly lower levels of
IgG than malaria-exposed adults (P,0.001) regardless of the
antigen. Expatriates with previous few exposures to malaria still
had significantly lower levels of antibodies compared to life-long
malaria-exposed individuals although the levels were higher than
naı̈ve subjects with the exceptions of IgG to MSP-142 FVO, EBA-
175 and DBL-a. Breadth of response was also significantly lower
in primo-infected individuals or expatriates compared to malaria-
exposed adults (data not shown).
Cytokine and chemokine responses in differently malaria-
exposed individuals
Cytokine measurements in individuals with an acute episode
showed that children, travelers and expatriates had significantly
higher levels of IFN-c than malaria-exposed individuals (median
{IQR} of 163.85 {51.33; 564.16}, 584.54 {77.17; 1446.56}, 44.03
{13.7; 199.72}, and 10.65 {0.8; 29} pg/mL, respectively;
P,0.0001, P,0.0001, P = 0.006, respectively) (Figure 2). In
addition, significantly higher levels of IL-2 were detected in
children (8.2 {8.2; 54.93} pg/mL), travelers (17.03 {8.2; 27.42}
pg/mL) and expatriates (15.77 {8.2; 19.7} pg/mL) compared to
malaria-exposed adults (8.2 {8.2; 8.2} pg/mL; P = 0.0379,
P = 0.0003, P = 0.0144, respectively). Children, travelers and
expatriates also had significantly higher concentrations of IL-8
(41.97 {30.02; 55.7}, 52.2 {32.72; 114.69} and 95.31 {31.86;
126.26} pg/mL, respectively) in comparison with malaria-exposed
adults (32.2 {14.69; 51.61}; P = 0.0233, P = 0.0029, P = 0.0035,
respectively). Compared to malaria-exposed adults, children also
had higher levels of IL-12 (13.33 {0.75; 191.81} vs. 0.75 {0.75;
17.98} pg/mL; P = 0.0001), IL-4 (10.94 {10.4; 333.6} vs. 10.4
{10.4; 14.99} pg/mL; P = 0.003), IL-1b (2.1 {2.1; 132.18} vs.
2.1{2.1; 7.3} pg/mL; P = 0.024) and TNF (1.6 {1.6; 56.97} vs. 1.6
{1.6; 1.6} pg/mL; P = 0.006).
In addition to the correlations between cytokines and parasitemia
in children and travelers described above, IFN-c, IL-4 and IL-1b
correlated significantly with parasitemia only in the expatriates
group (Table S2). None of the cytokines/chemokines tested
correlated significantly with parasitemia in malaria-exposed adults.
No correlations between cytokines and antibodies were
observed in any study group (data not shown).
Discussion
Results comparing naı̈ve adults and children indicate that age
has no prominent role in the immune responses induced during a
first malaria episode. Differences were found only in IgG responses
to MSP-142 3D7 and to a parasite from a pregnant woman, and in
IL-12 concentrations in serum/plasma. All three responses were
higher in children. In addition, at convalescence children had
higher levels of IL-10 and there were no differences in antibody
levels or seroprevalences, although for travelers only 6 samples out
of 22 were available at day 28 of convalescence.
IL-12 has been associated with protection against malaria
[29,30] and severe disease [31,32]. IL-12 is a TH1 cytokine
produced mainly by dendritic cells (DC) in response to Toll-Like-
Receptor (TLR) stimulation. It induces and regulates DC
maturation and function and promotes IFN-c production by T
cells and NK cells as well as their activation [33,34]. Here
increased levels of IL-12 indicate a higher innate immune response
in younger children, probably due to an age-differential response
to TLR ligands [4]. This could contribute to the lower risk of
severe complications and different clinical presentations described
in naı̈ve adults compared to children [2,12].
At convalescence, children had higher levels of the anti-
inflammatory cytokine IL-10 than naı̈ve adults. Therefore, the
total change in magnitude of this cytokine in acute vs.
convalescence was significantly lower in children compared to
adults, suggesting different capacity of regulating the pro-
inflammatory response. The observation that children had higher
levels of TNF and IL-1b in acute phase compared to life-long
malaria-exposed adults also suggests a different ability to regulate
pro-inflammatory and anti-inflammatory responses according to
age and/or exposure. Nevertheless, most children were P.
Table 3. Plasma IgG levels and seroprevalences in children and travelers in convalescence (day 28) after a first episode of P.
falciparum malaria.
IgG levels (AU) Prevalences





Antigens Median (IQR) Median (IQR) P-valuea n % n % P-valueb
Proteins
AMA-1 3D7 12459.59 (2442.78; 25005.45) 7211.44 (516.28; 11636.50) 0.5571 25 89 6 100 1.000
AMA-1 FVO 13248.19 (1622.11; 23681.75) 12544.35 (7112.02; 21767.80) 0.7861 21 75 5 83 1.000
MSP-1 3D7 21629.75 (17970.65; 30033.10) 21027.6 (16816.20; 22336.90) 0.4981 27 96 6 100 1.000
MSP-1 FVO 24619.3 (17512.80; 33060.50) 26869.15 (20308.50; 30278.10) 0.6191 25 89 6 100 1.000
EBA-175 595.58 (38.64; 1251.93) 753.07 (290.80; 1070.08) 0.7181 3 11 6 100 1.000
DBLa 410.65 (313.82; 993.56) 821.74 (271.98; 1430.16) 0.4421 3 11 5 83 1.000
DBL3X 137.11 (82.10; 656.53) 94.51 (74.86; 131.44) 0.3201 9 32 0 0 0.559
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falciparum PCR positive at day 28 (data not shown), although they
were treated with anti-malarial drugs and they did not have fever
or microscopic parasitemia. Conversely, none of the adults were
PCR positive at convalescence. It is possible that the higher IL-10
levels at convalescence were reflecting a response to submicro-
scopic parasitemia from uncleared/recrudescent or new infections.
However, the most plausible explanation is that PCR positives
were due to residual parasite DNA in dead IEs remaining in
circulation [35].
Comparisons between individuals with different levels of
exposure to P. falciparum allowed us to identify IFN-c, IL-2 and
IL-8 as cytokines/chemokines involved in cellular immune
responses to P. falciparum. As expected, increasing exposure
showed to be associated to an increase of antibody levels against
any antigen, but in this study we were unable to evaluate its role in
Figure 1. Plasma/serum cytokine levels in children and adults during a first malaria episode. A) Plasma/serum cytokine/chemokine
concentrations in the acute phase (dark grey) and convalescence (light grey) were compared between children and adults using the Mann-Whitney
test. B) Significantly different day 0/day 28 ratio cytokine levels in children and adults.
doi:10.1371/journal.pone.0055756.g001
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immunity. Compared to antibodies, the more moderate cytokine
responses may reflect naturally acquired immunity that allows a
better control of pro-inflammatory responses rather than mere
exposure. Although IFN-c has been associated with malaria
protection [29,36] and IL-2 may be key for the generation of
effector responses to malaria [36,37], the strong TH1 and
inflammatory responses detected reflect innate rather than
protective adaptive immune responses. Moreover, levels of IL-1b
and TNF were higher in children compared to malaria-exposed
adults during acute infection despite having a trend to lower
parasite density than malaria-exposed adults mounting a higher
antibody response to infection. This reinforces the idea that naı̈ve
individuals have stronger pro-inflammatory responses that would
be independent from the parasite biomass and may be key factors
to the prognosis of clinical episodes. Children also presented
significantly higher IL-4 levels compared to malaria-exposed
adults. It has been described that IL-4 promotes IL-12 DC
secretion [38], which is in line with the higher IL-12 levels found
in children compared to adults. The higher TH1/pro-inflamma-
tory responses observed in naı̈ve individuals were not caused by
higher parasite densities. Although we could not compare
parasitemias between all groups because of different methods
used to assess parasite density, there were no significant differences
between children and malaria-exposed adults or between travelers
and expatriates. Additionally, correlations between cytokines and
parasitemia showed that cytokines differently expressed in naı̈ve
versus malaria-exposed individuals (IL-12, IFN-c, IL-2, IL-1b and
TNF) did not show to be associated with parasitemia with the
exception of IL-8 in naı̈ve adults. These results suggest that these
cytokines are not directly affected by parasitemia and the
differences observed in cytokine concentrations may not be a
direct effect of differences in parasite densities among the groups.
Moreover, the fact that the correlations between cytokines and
parasite densities were different among groups might be a
reflection of different mechanisms of cytokine regulation depend-
ing on age and immunity.
Hence, our data may be reflecting development of tolerance, a
recognized mechanism of acquisition of immunity to P. falciparum
Table 4. Plasma IgG levels in an acute episode of differently exposed individuals.
IgG levels, median AU (IQR) P-value a


















































































































































Abbreviations: AU, Arbitrary units; IQR, Interquartile range; MalExp, Malaria-Exposed; Trav, Travelers; Expat, Expatriates; IEs, Infected erythrocytes.
aThe Mann-Whitney test was used.
bDeterminations were done in children n = 28.
cDeterminations were done in expatriates n = 5.
doi:10.1371/journal.pone.0055756.t004
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[39]. Tolerance has been described to be associated with less
expression of co-stimulatory molecules, less IL-6, IL-12, TNF and
IFN-c (pro-inflammatory cytokines) and an attenuation of cell
signaling. Mechanisms may include TLR tolerance due to
repeated antigen stimulation [40,41], tolerogenic DC [42,43],
regulatory T cells [44,45] and exhausted T cells [46].
Antibody seroprevalences in children and naı̈ve adults were
quite elevated with the exception of EBA-175, considering that
IgG levels were determined at the acute phase of a first malaria
Figure 2. Plasma/serum cytokine/chemokine concentrations (pg/mL) in the acute phase of differently exposed subjects. Mann-
Whitney test was used to compare children, travelers and expatriates (Expat) to malaria-exposed adults (MalExp).
doi:10.1371/journal.pone.0055756.g002
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episode. Study children were from a malaria endemic area and it is
plausible that they might have been previously exposed to P.
falciparum infection (i.e. after birth or in utero [47]). However, they
were followed up closely by active and passive morbidity
surveillance and we are quite confident that we captured the first
malaria episode. In addition, cytokine and antibody responses did
not show any significant association with in utero exposure
through maternal malaria infection (placental infection or cord
infection). In fact, IgG responses to most antigens, except those
described above, were not higher in children than adults.
Regarding IgG responses to the pregnant woman parasite isolate,
it could be due to passively transferred maternal antibodies against
CSA-binding parasites, however it is unlikely that these children
still had antibodies from the mother because they had a median
age of 1.1 years with the youngest one being 10.8 months old. IgG
detected in seropositive children and travelers are probably
reflecting the beginning of the antibody response to blood-stage
antigens even if few days had passed since the release of merozoites
from the liver [48]. Antibody responses were quite low and both
IgG levels and seroprevalences increased considerably at conva-
lescence, and were consistently lower than those of expatriates or
life-long malaria-exposed adults. In addition, several days may
have passed before traveler patients attended the Tropical
Medicine Unit.
Overall, antibody results are consistent with previous data of
acquired immunity in which there are two levels of immunity, one
strain-specific that is slowly acquired by consecutive exposures to
polymorphic antigens and another transcending antigenic diversity
[8]. In travelers, a single P. falciparum infection can be sufficient to
induce antibodies reactive with several PfEMP-1 variants that are
already detected at initial presentation to the hospital [48]. Also a
quite extensive breath of agglutination specificities was reported in
migrants from a non-endemic to an endemic zone considering a
relatively short time of exposure [49]. However, the degree of
cross-reactivity among strains seems to correlate with age [8]. In
our study, no differences in median breadth of response were
detected between children and naı̈ve adults against recombinant
proteins or VSAs, which had a very low breadth response. In
contrast, expatriates were responding to more antigens and
malaria-exposed adults showed a significantly higher breadth of
response compared to less exposed groups. The fact that travelers
were exposed to geographically distinct strains of P. falciparum
seems not to affect the antibody response to the tested antigens and
VSAs from Mozambican strains as they responded similarly to
children from Mozambique. Similar observations were reported in
people with limited histories of exposure who showed broad
agglutination activity against geographically diverse isolates [50]
or in a study were IgG VSA recognition was independent of the
geographical origin of parasites [51].
IgG seroprevalence to DBL-a in children was about 15%, lower
than what has been described in Manhiça children [32], although
in that study children were older and some have had previous
malaria episodes. Antibodies against DBL-a have been linked to
natural acquisition of immunity [26], to reduced risk of clinical
malaria [52], and have been associated with protection from
severe malaria [32]. The prevalence of antibodies against DBL3X
was about 30% in children, which is similar to a recent study that
suggested recognition of the VAR2CSA DBL5e domain in young
children [28]. Therefore our results contribute to the hypothesis
that exposure to VAR2CSA-expressing parasites is probably
common throughout early childhood [53]. Nevertheless, the
recognition of pregnancy-specific CSA-binding parasites was
about 10% in children and less in travelers.
To our knowledge only antibodies against MSP-2 3D7, RESA
and GPI have been correlated with age independently of exposure
[49,54]. Our study is limited by a number of factors that may mask
the detection of other age-dependent differences. For instance,
differences due to the African vs. European origin of the comparison
groups may confound the results. IgM, IgG isotype levels and
antibody affinity need to be determined in follow up studies. IgM
responses are relevant in a first malaria episode and the protective
effect of IgG isotypes has been attributed to the cytophilic subclasses
IgG1 and IgG3 [22,55,56]. In addition, affinity seems to increase
with age and is associated with protection [57].
In conclusion, age appeared not to be a significant factor in the
immune response to a first malaria episode, particularly for the
antibody responses examined. However, some observations such
as higher levels of IL-12 or higher pro-inflammatory responses in
children may indicate that some cellular age-dependent responses
have remained undetected in this study. Exposure to P. falciparum
was clearly associated with higher levels of IgG antibodies against
merozoite antigens and IEs, although we could not dissect their
role in immunity. Exposure to malaria and consequently, naturally
acquired immunity, was associated with lower levels of TH1 and
pro-inflammatory cytokines, indicating a more regulated and
balanced innate response related to mechanisms of tolerance.
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Transcription of var genes other than var2csa in Plasmodium falciparum
parasites infecting Mozambican pregnant women. J Infect Dis 204: 27–35.
14. Kocken CHM, Withers-Martinez C, Dubbeld MA, Van der Wel A, Hackett F,
et al. (2002) High-level expression of the malaria blood-stage vaccine candidate
Plasmodium falciparum apical membrane antigen 1 and induction of antibodies
that inhibit erythrocyte invasion. Infect Immun 70: 4471–4476.
15. Pandey KC, Singh S, Pattnaik P, Pillai CR, Pillai U, et al. (2002) Bacterially
expressed and refolded receptor binding domain of Plasmodium falciparum
EBA-175 elicits invasion inhibitory antibodies. Mol Biochem Parasitol 123: 23–
33.
16. Mayor A, Rovira-Vallbona E, Srivastava A, Sharma SK, Pati SS, et al. (2009)
Functional and immunological characterization of a Duffy binding-like alpha
domain from Plasmodium falciparum erythrocyte membrane protein 1 that
mediates rosetting. Infect Immun 77: 3857–3863.
17. Bir N, Yazdani SS, Avril M, Layez C, Gysin J, et al. (2006) Immunogenicity of
Duffy binding-like domains that bind chondroitin sulfate A and protection
against pregnancy-associated malaria. Infect Immun 74: 5955–5963.
18. Angov E (2003) Development and pre-clinical analysis of a Plasmodium
falciparum Merozoite Surface Protein-142 malaria vaccine. Mol Biochem
Parasitol 128: 195–204.
19. Angov E, Hillier CJ, Kincaid RL, Lyon JA (2008) Heterologous protein
expression is enhanced by harmonizing the codon usage frequencies of the target
gene with those of the expression host. PloS One 3: e2189.
20. Campo JJ, Dobaño C, Sacarlal J, Guinovart C, Mayor A, et al. (2011) Impact of
the RTS,S Malaria Vaccine Candidate on Naturally Acquired Antibody
Responses to Multiple Asexual Blood Stage Antigens. PloS One 6: e25779.
21. Richards JS, Stanisic DI, Fowkes FJI, Tavul L, Dabod E, et al. (2010)
Association between naturally acquired antibodies to erythrocyte-binding
antigens of Plasmodium falciparum and protection from malaria and high-
density parasitemia. Clin Infect Dis 51: e50–60.
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malaria be in pregnant women? Diagnosis by microscopy, placental histology,
polymerase chain reaction and detection of histidine-rich protein 2 in plasma.
Clin Infect Dis 54: 1561–1568.
36. McCall MBB, Sauerwein RW (2010) Interferon-c – central mediator of
protective immune responses against the pre-erythrocytic and blood stage of
malaria. J Leukoc Biol 88: 1131–1143.
37. Horowitz A, Newman KC, Evans JH, Korbel DS, Davis DM, et al. (2010)
Cross-talk between T cells and NK cells generates rapid effector responses to
Plasmodium falciparum-infected erythrocytes. J Immunol 184: 6043–6052.
38. Cook PC, Jones LH, Jenkins SJ, Wynn T a, Allen JE, et al. (2012) Alternatively
activated dendritic cells regulate CD4+ T-cell polarization in vitro and in vivo.
Proc Natl Acad Sci U S A 109: 2–7.
39. Boutlis CS, Yeo TW, Anstey NM (2006) Malaria tolerance – for whom the cell
tolls? Trends Parasitol 22: 371–377.
40. Perry JA, Olver CS, Burnett RC, Avery AC (2005) Cutting edge: the acquisition
of TLR tolerance during malaria infection impacts T cell activation. J Immunol
174: 5921–5925.
41. Broad A, Kirby JA, Jones DEJ (2007) Toll-like receptor interactions: tolerance of
MyD88-dependent cytokines but enhancement of MyD88-independent inter-
feron-beta production. Immunology 120: 103–111.
42. Rutella S, Danese S, Leone G (2006) Tolerogenic dendritic cells: cytokine
modulation comes of age. Blood 108: 1435–1440.
43. Stevenson MM, Urban BC (2006) Antigen presentation and dendritic cell
biology in malaria. Parasite Immunol 28: 5–14.
44. Hansen DS, Schofield L (2010) Natural regulatory T cells in malaria: host or
parasite allies? PLoS Pathog 6: e1000771.
45. Walther M, Jeffries D, Finney OC, Njie M, Ebonyi A, et al. (2009) Distinct roles
for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to
uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog 5:
e1000364.
46. Gigley JP, Bhadra R, Moretto MM, Khan IA (2012) T cell exhaustion in
protozoan disease. Trends Parasitol 28: 377–384.
47. Metenou S, Suguitan AL, Long C, Leke RGF, Taylor DW (2007) Fetal immune
responses to Plasmodium falciparum antigens in a malaria-endemic region of
Cameroon. J Immunol 178: 2770–2777.
48. Elliott SR, Payne PD, Duffy MF, Byrne TJ, Tham W-H, et al. (2007) Antibody
recognition of heterologous variant surface antigens after a single Plasmodium
falciparum infection in previously naive adults. Am J Trop Med Hyg 76: 860–
864.
49. Reeder JC, Davern KM, Baird JK, Rogerson SJ, Brown G V (1997) The age-
specific prevalence of Plasmodium falciparum in migrants to Irian Jaya is not
attributable to agglutinating antibody repertoire. Acta Trop 65: 163–173.
50. Aguiar JC, Albrecht GR, Cegielski P, Greenwood BM, Jensen JB, et al. (1992)
Agglutination of Plasmodium falciparum-infected erythrocytes from east and
west African isolates by human sera from distant geographic regions. Am J Trop
Med Hyg 47: 621–632.
51. Nielsen MA, Vestergaard LS, Lusingu J, Kurtzhals JAL, Giha HA, et al. (2004)
Geographical and temporal conservation of antibody recognition of Plasmodium
falciparum variant surface antigens. Infect Immun 72: 3531–3535.
52. Mackintosh CL, Christodoulou Z, Mwangi TW, Kortok M, Pinches R, et al.
(2008) Acquisition of naturally occurring antibody responses to recombinant
protein domains of Plasmodium falciparum erythrocyte membrane protein 1.
Malar J 7: 155.
53. Beeson JG, Ndungu F, Persson KEM, Chesson JM, Kelly GL, et al. (2007)
Antibodies among men and children to placental-binding Plasmodium
falciparum-infected erythrocytes that express var2csa. Am J Trop Med Hyg
77: 22–28.
54. Hudson Keenihan SN, Ratiwayanto S, Soebianto S, Krisin, Marwoto H, et al.
(2003) Age-dependent impairment of IgG responses to glycosylphosphatidyli-
nositol with equal exposure to Plasmodium falciparum among Javanese migrants
to Papua, Indonesia. Am J Trop Med Hyg 69: 36–41.
55. Roussilhon C, Oeuvray C, Müller-Graf C, Tall A, Rogier C, et al. (2007) Long-
term clinical protection from falciparum malaria is strongly associated with IgG3
antibodies to merozoite surface protein 3. PLoS Med 4: e320.
56. Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, et al. (2009)
Immunoglobulin G subclass-specific responses against Plasmodium falciparum
merozoite antigens are associated with control of parasitemia and protection
from symptomatic illness. Infect Immun 77: 1165–1174.
57. Reddy SB, Anders RF, Beeson JG, Färnert A, Kironde F, et al. (2012) High
affinity antibodies to Plasmodium falciparum merozoite antigens are associated
with protection from malaria. PloS ONE 7: e32242.
Immune Responses First Malaria Episode
PLOS ONE | www.plosone.org 10 February 2013 | Volume 8 | Issue 2 | e55756
